Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
Grange F, Petrella T, Beylot-Barry M, Joly P, D'Incan M, Delaunay M, Machet L, Avril MF, Dalac S, Bernard P, Carlotti A, Esteve E, Vergier B, Dechelotte P, Cassagnau E, Courville P, Saiag P, Laroche L, Bagot M, Wechsler J. Grange F, et al. Among authors: laroche l. Blood. 2004 May 15;103(10):3662-8. doi: 10.1182/blood-2003-08-2726. Epub 2004 Jan 15. Blood. 2004. PMID: 14726400 Free article.
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T. Grange F, et al. Among authors: laroche l. Arch Dermatol. 2007 Sep;143(9):1144-50. doi: 10.1001/archderm.143.9.1144. Arch Dermatol. 2007. PMID: 17875875
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
Grange F, Hedelin G, Joly P, Beylot-Barry M, D'Incan M, Delaunay M, Vaillant L, Avril MF, Bosq J, Wechsler J, Dalac S, Grosieux C, Franck N, Esteve E, Michel C, Bodemer C, Vergier B, Laroche L, Bagot M. Grange F, et al. Among authors: laroche l. Blood. 1999 Jun 1;93(11):3637-42. Blood. 1999. PMID: 10339469 Free article.
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
Grange F, Joly P, Barbe C, Bagot M, Dalle S, Ingen-Housz-Oro S, Maubec E, D'Incan M, Ram-Wolff C, Dalac S, Templier I, Esteve E, Quereux G, Machet L, Leduc M, Dereure O, Laroche L, Saiag P, Vergier B, Beylot-Barry M. Grange F, et al. Among authors: laroche l. JAMA Dermatol. 2014 May;150(5):535-41. doi: 10.1001/jamadermatol.2013.7452. JAMA Dermatol. 2014. PMID: 24647650
HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.
Sonigo G, Battistella M, Beylot-Barry M, Ingen-Housz-Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, Brice P, Boccara O, Bodemer C, Adamski H, D'Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marçais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahé A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Herve G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Bléchet C, Kerdraon R, Lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guerin F, Sepulveda FE, Bagot M, de Saint Basile G, Michonneau D, de Masson A. Sonigo G, et al. Among authors: laroche l. Blood. 2020 Mar 26;135(13):1058-1061. doi: 10.1182/blood.2019003811. Blood. 2020. PMID: 32005988 Free article. No abstract available.
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases.
Beylot-Barry M, Vergier B, Masquelier B, Bagot M, Joly P, Souteyrand P, Vaillant L, Avril MF, Franck N, Fraitag S, Delaunay M, Laroche L, Estève E, Courville P, Dechelotte P, Beylot C, De Mascarel A, Wechsler J, Merlio JP. Beylot-Barry M, et al. Among authors: laroche l. Am J Surg Pathol. 1999 Oct;23(10):1208-16. doi: 10.1097/00000478-199910000-00005. Am J Surg Pathol. 1999. PMID: 10524521
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E, Bagot M, Joly P, Souteyrand P, Beylot-Barry M, Vaillant L, Delaunay M, Avril MF, Laroche L, Grange F, Thomine E, Wechsler J. Estève E, et al. Among authors: laroche l. Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349. Arch Dermatol. 1999. PMID: 10566833
[Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
Grange F, D'Incan M, Ortonne N, Dalac S, Laroche L, Beylot-Barry M, Delfau-Larue MH, Vergier B, Bagot M; pour le Groupe français d’étude des lymphomes cutanés. Grange F, et al. Among authors: laroche l. Ann Dermatol Venereol. 2010 Aug-Sep;137(8-9):523-31. doi: 10.1016/j.annder.2010.04.016. Epub 2010 Jun 18. Ann Dermatol Venereol. 2010. PMID: 20804896 French.
516 results